'Reverse Patent Trolls'

“A small minority of drug companies are abusing the patent system to sustain invalid patents that contain no meaningful innovations but serve to maintain their anti-competitive high-price monopoly,” Bass wrote in an e-mail
http://www.bloomberg.com/news/articles/2015-04-02/hayman-s-kyle-bass-targets-shire-in-new-drug-patent-challenges